Overdoses decrease but synthetic risk increases in the United States

Las overdose deaths in USA They maintain a downward trend, but specialists warn that the outlook is far from encouraging. The illicit market has shifted toward increasingly complex synthetic mixtures, complicating medical care and increasing clinical uncertainty, according to data from the Centers for Disease Control and Prevention (CDC).

The provisional figures report 72 thousand 108 deaths for drugs in the 12 months prior to September 2025a year-on-year reduction of 19%.

However, organizations such as Drug Policy Alliance point out that regulatory pressure on fentanyl—accentuated during the administration of Donald Trumpwhich opted for punitive measures, expansion of police capabilities and classification of emerging substances—encouraged the appearance of mixtures designed to evade routine controls and tests.

You may also be interested in: This is how the world narrated the dejection of ‘El Mencho’

This approach prioritized the frontal fight against trafficking, but also accelerated chemical diversification in clandestine markets.

US forensic laboratories identify increasing use of veterinary tranquilizers

At the same time, forensic laboratories identify the growing use of veterinary tranquilizers—xylazine and medetomidine—combined with opioids. These substances, originally intended for large animals, generate deep ulcers, severe infections and, in extreme cases, amputations, in addition to reducing the effectiveness of the naloxone (Narcan) by causing a simultaneous picture of respiratory, cardiovascular and neurological depression.

You may also be interested in: Shooting at Mar-a-Lago reawakens alert about Trump

Another emerging vector is the so-called “pink cocaine” o bookdetected in large cities with variable compositions that may include ketamine, MDMAmethamphetamine or traces of fentanylwhich makes its power unpredictable.

As state laboratories face lags in identifying new compounds, medical personnel increasingly rely on symptomatic observation.

Thus, although the statistics reflect a decrease, the transition towards a more synthetic, fragmented and experimental market maintains a high health risk.

Source

Be the first to comment

Leave a Reply

Your email address will not be published.


*